CLEVELAND, July 10, 2019 — Eversight announces the appointment of Onkar B. Sawant, Ph.D., as Director of Research to oversee the organisation’s extensive research initiatives that aim to advance the field of vision science and eye banking practices to improve outcomes for patients. Sawant will be responsible for all research and development activities, in addition to leading the Eversight Center for Vision and Eye Banking Research located in Cleveland.
Eversight has a longstanding track record of research and development, to date awarding more than $4 million in grants that stimulate pioneering clinical and basic science research aiming to develop new ways to restore sight, prevent blindness and ultimately help patients live life to the fullest. The organisation also facilitates research initiatives driven by Eversight team members who are actively involved in ocular research and regularly publish in prestigious peer-reviewed journals.
“Eversight is a leader in eye banking in part because of its proven dedication to clinical innovation and cutting-edge technology,” Sawant said. “I am honored to join this trusted organization and am confident we will continue to invest in research and development that will advance vision therapies and transform lives.”
“Eversight has a robust research and development history that uniquely positions us to drive innovation during this time of continuous evolution in the eye banking industry,” said David Bosch, Eversight President & CEO. “We welcome Dr. Sawant and trust in his ability to expand our portfolio of groundbreaking research that results in innovative therapies and advanced products to continue making vision a reality.”